Sophia J. Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sophia J. Wu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Frances H. Arnold
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States
3 shared publications - Kendall. N. Houk
Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, USA
2 shared publications - Runze Mao
Division of Chemistry and Chemical Engineering California Institute of Technology Pasadena California 91225 United States
2 shared publications - Torben Rogge
Institut für Chemie, Technische Universität Berlin, Straße des 17. Juni 115, 10623 Berlin, Germany
2 shared publications Zi-Qi Li
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California, USA
2 shared publicationsZi-Yang Qin
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California, USA
2 shared publications
Latest Publications
- 23 September 2026
- Published by Springer Nature in Nature
- Vol. 659 (8140) , 378-385
Chiral oxazolidinones via biocatalytic aziridination of unactivated alkenes
- 23 September 2026
- Published by Springer Nature in Nature
- Vol. 659 (8140) , 378-385
Chiral oxazolidinones via biocatalytic aziridination of unactivated alkenes
- 3 May 2024
- Published by Springer Nature in Nature Catalysis
- Vol. 7 (5) , 585-592
Biocatalytic, enantioenriched primary amination of tertiary C–H bonds
Intermolecular functionalization of tertiary C–H bonds to construct fully substituted stereogenic carbon centres represents a formidable challenge: without the assistance of directing groups, state-of-the-art catalysts struggle to introduce chirality to racemic tertiary sp3-carbon centres. Direct asymmetric functionalization of such centres is a worthy reactivity and selectivity goal for modern biocatalysis. Here we present an engineered nitrene transferase (P411-TEA-5274), derived from a bacterial cytochrome P450, that is capable of aminating tertiary C–H bonds to provide chiral α-tertiary primary amines with high efficiency (up to 2,300 total turnovers) and selectivity (up to >99% enantiomeric excess). The construction of fully substituted stereocentres with methyl and ethyl groups underscores the enzyme’s remarkable selectivity. A comprehensive substrate scope study demonstrates the biocatalyst’s compatibility with diverse functional groups and tertiary C–H bonds. Mechanistic studies explain how active-site residues distinguish between the enantiomers and enable the enzyme to perform this transformation with excellent enantioselectivity.
- 3 May 2024
- Published by Springer Nature in Nature Catalysis
- Vol. 7 (5) , 585-592
Biocatalytic, enantioenriched primary amination of tertiary C–H bonds
Intermolecular functionalization of tertiary C–H bonds to construct fully substituted stereogenic carbon centres represents a formidable challenge: without the assistance of directing groups, state-of-the-art catalysts struggle to introduce chirality to racemic tertiary sp3-carbon centres. Direct asymmetric functionalization of such centres is a worthy reactivity and selectivity goal for modern biocatalysis. Here we present an engineered nitrene transferase (P411-TEA-5274), derived from a bacterial cytochrome P450, that is capable of aminating tertiary C–H bonds to provide chiral α-tertiary primary amines with high efficiency (up to 2,300 total turnovers) and selectivity (up to >99% enantiomeric excess). The construction of fully substituted stereocentres with methyl and ethyl groups underscores the enzyme’s remarkable selectivity. A comprehensive substrate scope study demonstrates the biocatalyst’s compatibility with diverse functional groups and tertiary C–H bonds. Mechanistic studies explain how active-site residues distinguish between the enantiomers and enable the enzyme to perform this transformation with excellent enantioselectivity.
- 2 November 2023
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (2) , 256-264
Biocatalytic, stereoconvergent alkylation of (Z/E)-trisubstituted silyl enol ethers
The selective conversion of mixtures of Z/E alkenes into chiral products is a synthetic challenge. Biocatalytic strategies can transform isomeric alkenes into stereopure compounds, but enzymes typically convert only one alkene isomer, limiting the overall yield. Additional strategies have been used to interconvert alkene isomers, often at the cost of increasing energy consumption and chemical waste. Here we present engineered haemoproteins derived from a bacterial cytochrome P450 that efficiently catalyse α-carbonyl alkylation of isomeric silyl enol ethers, producing stereopure products. Through screening and directed evolution, we generated P450BM3 variant P411-SCA-5188, which catalyses stereoconvergent carbene transfer in Escherichia coli with high efficiency and stereoselectivity to various Z/E mixtures of silyl enol ethers. In contrast to established stereospecific transformations that leave one isomer unreacted, P411-SCA-5188 converts both isomers to a stereopure product. This biocatalytic approach simplifies the synthesis of chiral α-branched ketones by eliminating the need for stoichiometric chiral auxiliaries, strongly basic alkali-metal enolates and harsh conditions, delivering products with high efficiency and excellent chemo- and stereoselectivities.
- 2 November 2023
- Published by Springer Nature in Nature Synthesis
- Vol. 3 (2) , 256-264
Biocatalytic, stereoconvergent alkylation of (Z/E)-trisubstituted silyl enol ethers
The selective conversion of mixtures of Z/E alkenes into chiral products is a synthetic challenge. Biocatalytic strategies can transform isomeric alkenes into stereopure compounds, but enzymes typically convert only one alkene isomer, limiting the overall yield. Additional strategies have been used to interconvert alkene isomers, often at the cost of increasing energy consumption and chemical waste. Here we present engineered haemoproteins derived from a bacterial cytochrome P450 that efficiently catalyse α-carbonyl alkylation of isomeric silyl enol ethers, producing stereopure products. Through screening and directed evolution, we generated P450BM3 variant P411-SCA-5188, which catalyses stereoconvergent carbene transfer in Escherichia coli with high efficiency and stereoselectivity to various Z/E mixtures of silyl enol ethers. In contrast to established stereospecific transformations that leave one isomer unreacted, P411-SCA-5188 converts both isomers to a stereopure product. This biocatalytic approach simplifies the synthesis of chiral α-branched ketones by eliminating the need for stoichiometric chiral auxiliaries, strongly basic alkali-metal enolates and harsh conditions, delivering products with high efficiency and excellent chemo- and stereoselectivities.